Row
C
CSTLAI Stock Diagnostic Report
Castle Biosciences president and CEO Derek Maetzold sells $515k stock
Castle Biosciences CEO Derek Maetzold sold approximately $515,000 worth of company stock, which could negatively impact investor sentiment.
View Source Article ↗
AI CATALYST SCORE40 / 100Score computed by Sentinel V12
REFERENCE PRICENot measuredReference entry price at analysis time
+ANALYSIS HISTORY
CSTL Analysis History (Last 30 Days)